The only product approved by the
US Food and Drug Administration
(FDA) for both cataplexy and EDS in
narcolepsy.1

XYREM is recommended by the American Academy of Sleep Medicine (AASM) as a standard of care for cataplexy and EDS in narcolepsy.2

XYREM, taken at night, has been shown to help relieve cataplexy and excessive daytime sleepiness (EDS) in narcolepsy during the day.1

PROPOSED XYREM MOA

Learn about how XYREM is thought to work.

PROPOSED XYREM MOA
XYREM CLINICAL TRIALS

Learn about XYREM for cataplexy and EDS in narcolepsy.

XYREM CLINICAL TRIALS
XYREM PATIENT STORIES

Explore how actual patients have experienced treatment with XYREM.

XYREM PATIENT STORIES

Find out about the pathophysiology of narcolepsy.

NEUROPHYSIOLOGY OVERVIEW

Get the facts about how to diagnose narcolepsy.

PATH TO DIAGNOSIS

Find out how cataplexy and EDS may affect your patients.

Find out how cataplexy and EDS may impact your patients HOW PATIENTS EXPERIENCE EDS HOW PATIENTS EXPERIENCE CATAPLEXY